Scarica l'app Stockscreener
212.26
2.02%
4.20
Pre-mercato:
224.00
11.74
+5.53%
Jazz Pharmaceuticals Plc Borsa (JAZZ) Ultime notizie
Jazz Pharmaceuticals Q1 Earnings Call Highlights - Yahoo Finance
Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance Singapore
Jazz (JAZZ) Q1 2026 Earnings Call Transcript - The Globe and Mail
MSN Money - MSN
Jazz Pharmaceuticals (JAZZ) Q1 Earnings and Revenues Top Estimates - Yahoo Finance Singapore
Earnings call transcript: Jazz Pharmaceuticals Q1 2026 earnings beat expectations By Investing.com - Investing.com Canada
Jazz Pharmaceuticals plc 2026 Q1ResultsEarnings Call Presentation (NASDAQ:JAZZ) 2026-05-05 - Seeking Alpha
Jazz Pharmaceuticals Q1 2026 Earnings Call: Complete Transcript - Benzinga
Jazz Pharmaceuticals surges on earnings beat, strong revenue By Investing.com - Investing.com South Africa
Jazz Pharmaceuticals surges on earnings beat, strong revenue - Investing.com
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surges 3.7% After-Hours on Q1 2026 Revenue and EPS Beat - ChartMill
Jazz: Q1 Earnings Snapshot - wwltv.com
(JAZZ) Jazz Pharmaceuticals Expects Full Year 2026 Revenue Range $4.25B$4.50B, vs. FactSet Est of $4.44B - marketscreener.com
Bruce Cozadd sells 6,000 Jazz (NASDAQ: JAZZ) shares under 10b5-1 plan - Stock Titan
Earnings Flash (JAZZ) Jazz Pharmaceuticals plc Reports Q1 Revenue $1.07B, vs. FactSet Est of $978.5M - marketscreener.com
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q1 CY2026 Sales - Yahoo Finance
Earnings Flash (JAZZ) Jazz Pharmaceuticals plc Posts Q1 Adjusted EPS $6.34 per Share - marketscreener.com
Jazz Pharmaceuticals (NASDAQ: JAZZ) swings to Q1 2026 profit on PRV sale - Stock Titan
Jazz Pharmaceuticals (NASDAQ: JAZZ) posts 19% Q1 revenue growth - Stock Titan
Jazz Pharmaceuticals Announces First Quarter 2026 Financial Results - PR Newswire
All eyes on Jazz Pharmaceuticals earnings as FDA decision nears By Investing.com - Investing.com Canada
All eyes on Jazz Pharmaceuticals earnings as FDA decision nears - Investing.com
Jazz Pharmaceuticals stock hits all-time high at 207.49 USD By Investing.com - Investing.com India
Jazz Pharmaceuticals stock hits all-time high at 207.49 USD - Investing.com
Jazz Pharmaceuticals (JAZZ) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by Mitsubishi UFJ Trust & Banking Corp - MarketBeat
Jazz Pharmaceuticals PLC (JAZZ) - MSN
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Ziihera Priority Review Milestone - simplywall.st
Jazz Pharmaceuticals (NASDAQ: JAZZ) reports two 6,000-share Rule 144 sales - Stock Titan
JAZZ Forecast, Price Target & Analyst Ratings | JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) - ChartMill
Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Sees Significant Decline in Short Interest - MarketBeat
Vanguard Capital Management reports 5.04% stake in Jazz Pharmaceuticals (NASDAQ: JAZZ) - Stock Titan
Will Ziihera’s Priority Review in First-Line HER2-Positive Gastric Cancer Shift Jazz Pharmaceuticals’ (JAZZ) Narrative? - simplywall.st
Pictet Asset Management Holding SA Sells 33,547 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
M&T Bank Corp Purchases New Shares in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
US Cannabis Market Report Analysis Report 2026-2034 Featuring Canopy Growth, Tilray Brands, Curaleaf, Aurora Cannabis, Jazz Pharma, GTI, Trulieve, Cresco Labs, Organigram Global, TerrAscend - Yahoo Finance
Jazz Pharmaceuticals (JAZZ) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Market Driver Insights: The Impact of Recent Developments on the Erwinaze/Spectrila Market - openPR.com
FDA accepts Jazz Pharma filing for Ziihera in gastric cancer By Investing.com - Investing.com South Africa
FDA accepts Jazz Pharma filing for Ziihera in gastric cancer - Investing.com UK
Wells Fargo Maintains Jazz Pharmaceuticals (JAZZ) Overweight Recommendation - MSN
How ASCO Phase 3 Oncology Data May Reshape Jazz Pharmaceuticals' (JAZZ) Investment Narrative - Yahoo Finance
Unpacking Q4 Earnings: Jazz Pharmaceuticals (NASDAQ:JAZZ) In The Context Of Other Pharmaceuticals Stocks - Yahoo Finance
Jazz Pharmaceuticals announces FDA acceptance and Priority Review of supplemental biologics license application for Ziihera - marketscreener.com
Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA - ChartMill
Jazz Pharmaceuticals (JAZZ) Stock Analysis: A Biotech Powerhouse with a 14.76% Upside Potential - DirectorsTalk Interviews
Jazz Pharmaceuticals enters exclusive licensing deal with Saniona - msn.com
Universal Beteiligungs und Servicegesellschaft mbH Has $15.32 Million Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Polaris Capital Management LLC Sells 81,000 Shares of Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals Executive Compensation Program 2025: Structure, Philosophy, and Key Features Explained - Minichart
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):